These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 34149728

  • 21. Molecular Subsetting of Interferon Pathways in Sjögren's Syndrome.
    Hall JC, Baer AN, Shah AA, Criswell LA, Shiboski CH, Rosen A, Casciola-Rosen L.
    Arthritis Rheumatol; 2015 Sep; 67(9):2437-46. PubMed ID: 25988820
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Amplified Type I Interferon Response in Sjögren's Disease via Ectopic Toll-Like Receptor 7 Expression in Salivary Gland Epithelial Cells Induced by Lysosome-Associated Membrane Protein 3.
    Nakamura H, Tanaka T, Zheng C, Afione SA, Atsumi T, Noguchi M, Oliveira FR, Motta ACF, Chahud F, Rocha EM, Warner BM, Chiorini JA.
    Arthritis Rheumatol; 2024 Jul; 76(7):1109-1119. PubMed ID: 38472139
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Abnormal interferon-inducible protein-10 expression in the labial glands of patients with Sjogren's syndrome].
    Zhou W, Dong Y, Zhao Y, Tang FL.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):603-7. PubMed ID: 14650168
    [Abstract] [Full Text] [Related]

  • 28. Synaptotagmin-1 overexpression under inflammatory conditions affects secretion in salivary glands from Sjögren's syndrome patients.
    Cortés J, Hidalgo J, Aguilera S, Castro I, Brito M, Urra H, Pérez P, Barrera MJ, Carvajal P, Urzúa U, González S, Molina C, Bahamondes V, Hermoso M, González MJ.
    J Autoimmun; 2019 Feb; 97():88-99. PubMed ID: 30391023
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Decreased salivary sulphotransferase activity correlated with inflammation and autoimmunity parameters in Sjogren's syndrome patients.
    Castro I, Aguilera S, Brockhausen I, Alliende C, Quest AF, Molina C, Urzúa U, Mandel U, Bahamondes V, Barrera MJ, Sánchez M, González S, Hermoso M, Leyton C, González MJ.
    Rheumatology (Oxford); 2012 Mar; 51(3):482-90. PubMed ID: 22101162
    [Abstract] [Full Text] [Related]

  • 32. Comparison of MicroRNA Expression in Tears of Normal Subjects and Sjögren Syndrome Patients.
    Kim YJ, Yeon Y, Lee WJ, Shin YU, Cho H, Sung YK, Kim DR, Lim HW, Kang MH.
    Invest Ophthalmol Vis Sci; 2019 Nov 01; 60(14):4889-4895. PubMed ID: 31752018
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Interleukin-7/Interferon Axis Drives T Cell and Salivary Gland Epithelial Cell Interactions in Sjögren's Syndrome.
    Rivière E, Pascaud J, Virone A, Dupré A, Ly B, Paoletti A, Seror R, Tchitchek N, Mingueneau M, Smith N, Duffy D, Cassard L, Chaput N, Pengam S, Gauttier V, Poirier N, Mariette X, Nocturne G.
    Arthritis Rheumatol; 2021 Apr 01; 73(4):631-640. PubMed ID: 33058491
    [Abstract] [Full Text] [Related]

  • 36. Activation of the type I interferon pathway in primary Sjogren's syndrome.
    Mavragani CP, Crow MK.
    J Autoimmun; 2010 Nov 01; 35(3):225-31. PubMed ID: 20674271
    [Abstract] [Full Text] [Related]

  • 37. Protein and DNA methylation-based scores as surrogate markers for interferon system activation in patients with primary Sjögren's syndrome.
    Björk A, Richardsdotter Andersson E, Imgenberg-Kreuz J, Thorlacius GE, Mofors J, Syvänen AC, Kvarnström M, Nordmark G, Wahren-Herlenius M.
    RMD Open; 2020 Jan 01; 6(1):. PubMed ID: 31958277
    [Abstract] [Full Text] [Related]

  • 38. Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome.
    Zhao J, Kubo S, Nakayamada S, Shimajiri S, Zhang X, Yamaoka K, Tanaka Y.
    Mod Rheumatol; 2016 Sep 01; 26(5):716-24. PubMed ID: 26706891
    [Abstract] [Full Text] [Related]

  • 39. Cystatin S-a candidate biomarker for severity of submandibular gland involvement in Sjögren's syndrome.
    Martini D, Gallo A, Vella S, Sernissi F, Cecchettini A, Luciano N, Polizzi E, Conaldi PG, Mosca M, Baldini C.
    Rheumatology (Oxford); 2017 Jun 01; 56(6):1031-1038. PubMed ID: 28339625
    [Abstract] [Full Text] [Related]

  • 40. miRNAs as potential biomarkers for subclinical atherosclerosis in Sjögren's disease.
    Zehrfeld N, Abelmann M, Benz S, Seeliger T, Engelke F, Skripuletz T, Baer C, Thum T, Witte T, Sonnenschein K, Ernst D, Derda AA.
    RMD Open; 2024 Aug 22; 10(3):. PubMed ID: 39179256
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.